Plains GP Holdings LP (NYSE:PAGP) had its price target upped by Howard Weil from $10.00 to $14.00 in a research report released on Monday morning. Howard Weil currently has a sector perform rating on the stock.

Other equities analysts have also recently issued research reports about the company. Barclays PLC cut Plains GP Holdings from an overweight rating to an equal weight rating and lifted their target price for the company from $8.00 to $11.00 in a research note on Friday, July 8th. Robert W. Baird raised Plains GP Holdings from an underperform rating to a neutral rating and lifted their target price for the company from $5.00 to $12.00 in a research note on Wednesday, July 13th. Morgan Stanley lifted their target price on Plains GP Holdings from $12.50 to $14.00 and gave the company an equal weight rating in a research note on Tuesday, October 4th. Wunderlich lifted their target price on Plains GP Holdings from $10.00 to $11.00 and gave the company a hold rating in a research note on Wednesday, August 31st. Finally, Zacks Investment Research cut Plains GP Holdings from a buy rating to a hold rating in a research note on Tuesday, July 12th. Eighteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company presently has an average rating of Hold and an average target price of $12.06.

Analyst Recommendations for Plains GP Holdings (NYSE:PAGP)

Plains GP Holdings (NYSE:PAGP) traded down 1.54% during mid-day trading on Monday, hitting $13.46. 212,212 shares of the stock were exchanged. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of 24.21 and a beta of 1.54. The company has a 50 day moving average price of $12.03 and a 200 day moving average price of $10.55. Plains GP Holdings has a 52 week low of $4.72 and a 52 week high of $19.11.

Plains GP Holdings (NYSE:PAGP) last posted its quarterly earnings data on Monday, August 8th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.19 by $0.04. The company had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.76 billion. Plains GP Holdings had a return on equity of 1.36% and a net margin of 0.69%. Plains GP Holdings’s quarterly revenue was down 25.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.27 EPS. Analysts expect that Plains GP Holdings will post $0.83 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Monday, October 31st will be issued a dividend of $0.2065 per share. This represents a $0.83 annualized dividend and a dividend yield of 6.04%. The ex-dividend date is Thursday, October 27th. Plains GP Holdings’s payout ratio is presently 170.37%.

Hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its stake in shares of Plains GP Holdings by 78.4% in the first quarter. JPMorgan Chase & Co. now owns 2,322,935 shares of the company’s stock valued at $20,188,000 after buying an additional 1,020,496 shares during the last quarter. LVW Advisors LLC boosted its stake in shares of Plains GP Holdings by 381.4% in the first quarter. LVW Advisors LLC now owns 59,575 shares of the company’s stock valued at $518,000 after buying an additional 47,200 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. acquired a new stake in shares of Plains GP Holdings during the first quarter valued at approximately $272,000. Cypress Wealth Advisors LLC boosted its stake in shares of Plains GP Holdings by 582.7% in the first quarter. Cypress Wealth Advisors LLC now owns 102,400 shares of the company’s stock valued at $890,000 after buying an additional 87,400 shares during the last quarter. Finally, UBS Group AG boosted its stake in shares of Plains GP Holdings by 19.8% in the first quarter. UBS Group AG now owns 640,266 shares of the company’s stock valued at $5,564,000 after buying an additional 105,801 shares during the last quarter. Institutional investors own 76.78% of the company’s stock.

About Plains GP Holdings

Plains GP Holdings, L.P. (PAGP) owns an interest in the general partner and incentive distribution rights (IDRs) of Plains All American Pipeline, L.P (PAA). The Company has no separate operating activities apart from those conducted by PAA. PAA owns and operates midstream energy infrastructure and provides logistics services for crude oil, natural gas liquids (NGL), natural gas and refined products.

5 Day Chart for NYSE:PAGP

Receive News & Stock Ratings for Plains GP Holdings LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP Holdings LP and related stocks with our FREE daily email newsletter.